Mather Group, Llc. Trans Medics Group, Inc. Transaction History
Mather Group, Llc.
- $7.67 Billion
- Q4 2024
A detailed history of Mather Group, Llc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 16 shares of TMDX stock, worth $973. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 16
-0.0%
Holding current value
$973
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TMDX
# of Institutions
394Shares Held
31.7MCall Options Held
466KPut Options Held
286K-
Vanguard Group Inc Valley Forge, PA3.6MShares$219 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$161 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.44MShares$87.7 Million2.22% of portfolio
-
State Street Corp Boston, MA1.27MShares$77.4 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.09MShares$66.5 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $1.94B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...